The impact of oxidative stress and immune function on the central nervous system and their association with depression and anxiety are well known (Lindqvist et al., 2017
Support emotional balancewith advanced peptide science
In the Phase 2 trial at 48 weeks (NEJM 2023): Every single participant on 12 mg lost at least 5% of their body weight
Obesity, like hypertension and hypothyroidism, has a substantial biological component, and GLP-1 medications address that biology directly
Concurrently, DFU exhibit a high recurrence rate, with up to 42% recurrence within one year [3]
Additionally, it can act as an appetite suppressant, though this side effect is not typically the primary reason people seek it out